These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 38026261)

  • 1. Sarcoplasmic Myxovirus Resistance Protein A: A Study of Expression in Idiopathic Inflammatory Myopathy.
    Waisayarat J; Wongsuwan P; Tuntiseranee K; Waisayarat P; Dejthevaporn C; Khongkhatithum C; Soponkanaporn S
    J Inflamm Res; 2023; 16():5417-5426. PubMed ID: 38026261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sarcoplasmic MxA expression: A valuable marker of dermatomyositis.
    Uruha A; Nishikawa A; Tsuburaya RS; Hamanaka K; Kuwana M; Watanabe Y; Suzuki S; Suzuki N; Nishino I
    Neurology; 2017 Jan; 88(5):493-500. PubMed ID: 28039312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic potential of sarcoplasmic myxovirus resistance protein A expression in subsets of dermatomyositis.
    Uruha A; Allenbach Y; Charuel JL; Musset L; Aussy A; Boyer O; Mariampillai K; Landon-Cardinal O; Rasmussen C; Bolko L; Maisonobe T; Leonard-Louis S; Suzuki S; Nishino I; Stenzel W; Benveniste O
    Neuropathol Appl Neurobiol; 2019 Aug; 45(5):513-522. PubMed ID: 30267437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myxovirus resistance protein A (MxA) expression in myositides: Sarcoplasmic expression is common in both dermatomyositis and lupus myositis.
    Xing C; Trivedi J; Bitencourt N; Burns DK; Reisch JS; Cai C
    Muscle Nerve; 2024 May; 69(5):548-555. PubMed ID: 38372203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Updates on the Immunopathology in Idiopathic Inflammatory Myopathies.
    Uruha A; Goebel HH; Stenzel W
    Curr Rheumatol Rep; 2021 Jul; 23(7):56. PubMed ID: 34212266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dermatomyositis: Muscle Pathology According to Antibody Subtypes.
    Tanboon J; Inoue M; Saito Y; Tachimori H; Hayashi S; Noguchi S; Okiyama N; Fujimoto M; Nishino I
    Neurology; 2022 Feb; 98(7):e739-e749. PubMed ID: 34873015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of Complement, Microangiopathy and Inflammation in Idiopathic Inflammatory Myopathies.
    Honda M; Shimizu F; Sato R; Nakamori M
    J Neuromuscul Dis; 2024; 11(1):5-16. PubMed ID: 38143369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Muscle Biopsy Features with Myositis Autoantibodies in Inflammatory Myopathies: A Pilot Experience.
    Gudipati A; Rifat S; Uppin M; Jabeen A; Mathukumalli NL; Yareeda S; Kayidhi S; Pyal A; Dhamne M; Reddy YM
    Ann Indian Acad Neurol; 2023; 26(4):408-418. PubMed ID: 37970294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolving classification and role of muscle biopsy in diagnosis of inflammatory myopathies.
    Swain M; Uppin M
    Indian J Pathol Microbiol; 2022 May; 65(Supplement):S241-S251. PubMed ID: 35562156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utilization of myositis antibody-specific panel for diagnosis, treatment, and evaluation of disease progression.
    Stark A; Hauptman H; Nguyen B; Mathew M; Aversano A; Mueller J
    J Community Hosp Intern Med Perspect; 2020 Sep; 10(5):462-465. PubMed ID: 33235684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammatory myopathies: an update for neurologists.
    Silva AMS; Campos ED; Zanoteli E
    Arq Neuropsiquiatr; 2022 May; 80(5 Suppl 1):238-248. PubMed ID: 35976321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymyositis: is there anything left? A retrospective diagnostic review from a tertiary myositis centre.
    Loarce-Martos J; Lilleker JB; Parker M; McHugh N; Chinoy H
    Rheumatology (Oxford); 2021 Jul; 60(7):3398-3403. PubMed ID: 33367878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of myxovirus-resistance protein A: a possible marker of muscle disease activity and autoantibody specificities in juvenile dermatomyositis.
    Soponkanaporn S; Deakin CT; Schutz PW; Marshall LR; Yasin SA; Johnson CM; Sag E; Tansley SL; McHugh NJ; Wedderburn LR; Jacques TS
    Neuropathol Appl Neurobiol; 2019 Jun; 45(4):410-420. PubMed ID: 29770465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammatory muscle disease - An update.
    Baig S; Paik JJ
    Best Pract Res Clin Rheumatol; 2020 Feb; 34(1):101484. PubMed ID: 32046904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Myositis: From classification to diagnosis].
    Fer F; Allenbach Y; Benveniste O
    Rev Med Interne; 2021 Jun; 42(6):392-400. PubMed ID: 33248855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphocyte immunophenotyping in inflammatory myositis: a review.
    Franco C; Gatto M; Iaccarino L; Ghirardello A; Doria A
    Curr Opin Rheumatol; 2021 Nov; 33(6):522-528. PubMed ID: 34402455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune-mediated necrotizing myopathy (IMNM): A myopathological challenge.
    Merlonghi G; Antonini G; Garibaldi M
    Autoimmun Rev; 2022 Feb; 21(2):102993. PubMed ID: 34798316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Where are we moving in the classification of idiopathic inflammatory myopathies?
    Tanboon J; Uruha A; Stenzel W; Nishino I
    Curr Opin Neurol; 2020 Oct; 33(5):590-603. PubMed ID: 32852298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Idiopathic Inflammatory Myopathies].
    Tomaras S; Kekow J; Feist E
    Dtsch Med Wochenschr; 2020 Jul; 145(13):903-910. PubMed ID: 32615605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating disease status in idiopathic inflammatory myopathies with quantitative muscle ultrasound.
    Tan JY; Tan CY; Yahya MA; Shahrizaila N; Goh KJ
    Muscle Nerve; 2024 May; 69(5):597-603. PubMed ID: 38488306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.